Upgrade to SI Premium - Free Trial

FDA grants priority review to Insmed's Arikayce for MAC lung disease

September 21, 2026 7:00 AM
The U.S. Food and Drug Administration has accepted and granted Priority Review to a Supplemental New Drug Application (sNDA) filed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA